Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in Florida compared to retail commercial list prices ($1050/mo).
Status: Available via 503A Pharmacies & Out-of-State Certified Shippers
Florida law permits patient-specific compounding of peptides when commercial medications are on FDA shortage or when a physician determines a customized clinical variation is required.
Statutory Citation: Fla. Stat. § 465.0255 & Florida Board of Pharmacy Rules 64B16
Florida law permits patient-specific compounding of peptides when commercial medications are on FDA shortage or when a physician determines a customized clinical variation is required.
Pharmacies compounding for Florida patients must hold a Florida Community Pharmacy or Nonresident Pharmacy permit and adhere strictly to USP <795> and <797> sterile preparation standards.
Browse deep clinical analysis and metabolic decision models on Groundwork.